stockmarketproxy
/
CORNYSESEC EDGAREDGAR

Cencora, Inc.

Wholesale-Drugs, Proprietaries & Druggists' Sundries·CONSHOHOCKEN, PA·FY end 09/30·CIK 1140859
OverviewFinancialsCompensationGovernanceInsidersFilings

Financials

5-year history · USD
MetricFY 2025FY 2024FY 2023FY 2022FY 2021Trend
Revenue$321.3B$294.0B$262.2B$238.6B$214.0B
Gross Profit$11.5B$9.9B$9.0B$8.3B$6.9B
Operating Income$2.6B$2.2B$2.3B$2.4B$2.4B
Net Income$1.6B$1.5B$1.7B$1.7B$1.5B
Operating CF$3.9B$3.5B$3.9B$2.7B$2.7B
Capex$668.0M$487.2M$458.4M$496.3M$438.2M
Free Cash Flow$3.2B$3.0B$3.5B$2.2B$2.2B
Buybacks$435.5M$1.5B$1.2B$483.7M$82.2M
Dividends$437.1M$416.2M$398.8M$391.7M$366.6M
Gross Margin3.6%3.4%3.4%3.5%3.2%
Operating Margin0.8%0.7%0.9%1.0%1.1%
Net Margin0.5%0.5%0.7%0.7%0.7%
FCF Margin1.0%1.0%1.3%0.9%1.0%
R&D / Revenue——————
Effective Tax30.6%24.2%19.8%23.7%30.5%
Debt / Equity10.0812.6917.11-48.8558.51
Buybacks / FCF13.6%49.8%34.2%21.9%3.7%

Peer comparison

Wholesale-Drugs, Proprietaries & Druggists' Sundries · 2 peers
CEO Pay Ratio
COR
198:1
MCK
295:1
CAH
261:1
CEO total comp
COR
$18M
MCK
$20M
CAH
$19M
Net Margin
COR
0.5%
MCK
1.2%
CAH
0.7%